1 Civil Systems Planning Benefit/Cost Analysis Scott Matthews Courses: 12-706 and 73-359 Lecture 17 - 11/5/2003.

Slides:



Advertisements
Similar presentations
Chapter 11 1 Chapter 11. Highway Traffic Safety: Studies, Statistics, and Programs Describe the trend in accident occurrences Explain approaches to highway.
Advertisements

Valuation of Non-Market Goods Lecture 5. Outline 1.Project Evaluation 2.The Need for Values of Non-Market Goods Cost benefit analysis Concepts of economic.
Section 3/6/2009  VSL  Static vs. Dynamic Efficiency (Example: optimal extraction of a non-renewable resource)  Defining/ measuring scarcity  Definitions.
The Great East Japan Earthquake and its Behavioral Implications: Makoto Saito, Hitotsubashi University.
Scaling Session Measurement implies “assigning numbers to objects or events…” Distinguish two levels: we can assign numbers to the response levels for.
ECON 6012 Cost Benefit Analysis Memorial University of Newfoundland
Exploring uncertainty in cost effectiveness analysis NICE International and HITAP copyright © 2013 Francis Ruiz NICE International (acknowledgements to:
Utility Assessment HINF Medical Methodologies Session 4.
317_L24, Mar 11/08, J. Schaafsma 1 Review of the Last Lecture are discussing shadow pricing in the context of cost-benefit analysis noted that shadow pricing.
A METHODOLOGY FOR MEASURING THE COST- UTILITY OF EARLY CHILDHOOD DEVELOPMENTAL INTERVENTIONS Quality of improved life opportunities (QILO)
Spring Valuation of Transportation Safety Value of Life Human Capital Direct Costs Output Losses Net Consumption Gross Output Willingness to Pay.
 Homework #2 due Thursday  Exam #1 on Thursday  Writing Assignment due Oct. 27th.
1 Civil Systems Planning Benefit/Cost Analysis Scott Matthews Courses: and Lecture /22/2004.
1 Civil Systems Planning Benefit/Cost Analysis Scott Matthews / and Lecture 2 - 9/1/2004.
1 Extreme Events Cost-Effectiveness Analysis Scott Matthews Courses: /
1 Social Discount Rate Scott Matthews Courses: and Lecture /20/2004.
1 Travel Costs Scott Matthews Courses: and Lecture /25/2004.
1 Value of Life Analysis Scott Matthews Courses: / /
1 Civil Systems Planning Benefit/Cost Analysis Scott Matthews Final Review Courses: and Lecture /2/2002.
1 Cost-Effectiveness Analysis Life Years Analysis Scott Matthews Courses: /
1 Civil Systems Planning Benefit/Cost Analysis Scott Matthews Courses: and Lecture /4/2002.
1 Civil Systems Planning Benefit/Cost Analysis Scott Matthews Courses: and Lecture 2 - 8/28/2002.
1 Social Discount Rate Travel Costs Scott Matthews Courses: and Lecture /15/2003.
1 Civil Systems Planning Benefit/Cost Analysis Scott Matthews Courses: and Lecture /6/2002.
1 Applications of Simulation Travel Costs Scott Matthews Courses: /
COST–EFFECTIVENESS ANALYSIS AND COST-UTILITY ANALYSIS
1 Civil Systems Planning Benefit/Cost Analysis Scott Matthews Courses: / / Lecture /14/2005.
AGEC 608 Lecture 14, p. 1 AGEC 608: Lecture 14 Objective: Provide overview of contingent valuation method (CVM) and review strengths and weaknesses of.
Measuring Environmental Benefits: Revealed Preference Approaches Travel Cost and Hedonic Methods.
1 Civil Systems Planning Benefit/Cost Analysis Scott Matthews Courses: and Lecture /7/2002.
Cohort Studies.
1 Cost-Effectiveness Analysis (CEA) Scott Matthews Courses: and Lecture /3/2003.
 Homework #8 due Next Thursday  Group Outline due Nov. 11 (next Thurs.)
AGEC 608 Lecture 17, p. 1 AGEC 608: Lecture 17 Objective: Review the main aspects of cost- effectiveness analysis (CEA) and cost-utility analysis (CUA).
1 Cost-Utility Analysis Cost-Effectiveness Analysis Scott Matthews Courses: / / Lecture /9/2005.
Chapter 4: Economic Efficiency and Cost Benefit Analysis 1.Economic Efficiency 2.Cost Benefit Analysis.
Health Economics & Policy 3 rd Edition James W. Henderson Chapter 4 Economic Evaluation in Health Care.
As we wait for class to start, please sign in for today’s attendance tracking: Text to 37607: ERASER netID Go online to AEM 4160 class website Click on.
Valuation of Intangibles. Measuring the value of outcomes (or social surplus) Two basic methods – Revealed preference (observing what people actually.
Cost-Effectiveness Problem l You have a $1.5 billion budget to spend on any combination of these programs:
DEPARTMENT OF PSYCHOLOGY WELLCOME DEPARTMENT OF IMAGING NEUROSCIENCE The Price of Pain and the Value of Suffering Ivo Vlaev, Ben Seymour, Ray Dolan, Nick.
Contingent Valuation Bangkok Stated Preference Attitudinal versus behavioral What people say are their values rather than the implicit values consistent.
Economics and Conservation, 2 Fri. April. 29. REVIEW: Cost Benefit Analysis (CBA) Overview Political observation – CBA was mandated for all new USA policies.
Knowing what you get for what you pay An introduction to cost effectiveness FETP India.
The Economic and Health Effects of Biomedical Innovation Peter R. Orszag Vice Chairman, Corporate and Investment Banking Chairman, Financial Strategy and.
What I was doing on Thursday during class.... Measuring Environmental Benefits: Revealed Preference Approaches Travel Cost and Hedonic Methods.
IN THE NAME OF GOD Flagship Course on Health Sector Reform and Sustainable Financing; Module 4: : How to construct.
Normative Criteria for Decision Making Applying the Concepts
Estimating Outcomes in Decision Analysis Brian Harris MPP Candidate Goldman School of Public Policy University of California, Berkeley.
Phaedra Corso, Ph.D. Associate Professor College of Public Health University of Georgia Program Evaluation from an Economic Perspective.
Chapter 3 Arbitrage and Financial Decision Making
Cost-Effectiveness and Cost-Benefit Analysis N287E Spring 2006 Joanne Spetz 31 May 2006.
Contingent Valuation Methods See Boardman et al., Chapter 14 Interview individuals to elicit their preferences for different states of the world. Based.
Chapter 4: Cost-Benefit Analysis Chapter 4 Cost-Benefit Analysis Copyright © 2009 by The McGraw-Hill Companies, Inc. All rights reserved. McGraw-Hill/Irwin.
Environmental Economics Class 4. Valuing the Environment: Methods Methodologies available for quantifying benefits and costs. Valuation techniques available.
GEF Session 10B From Diye to Value of Statistical Life: A Case Study for the Islamic Republic of Iran Morteza Rahmatian California State University, Fullerton.
Quality of life of alcohol-related diseases and road accidents in Switzerland: An economic assessment France Priez The University of North Carolina at.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 13: Cost-benefit analysis – Part 2.
Copyright © 2009 Pearson Addison-Wesley. All rights reserved. Chapter 3 Valuing the Environment: Methods.
Measuring Environmental Benefits. In principle, benefits can be represented by consumer surplus, or the area under the demand curve: Market good sold.
Introduction to decision analysis Jouni Tuomisto THL.
GEF Caspian EVE 2005/UNDP and WBI Morteza Rahmatian, Value of Statisical Life Session 10A Value of Statistical Life Morteza Rahmatian California State.
Cost and Benefits. Introduction Is treatment X worth it?
Copyright © 2009 Pearson Education, Inc. 6.4 Ideas of Risk and Life Expectancy LEARNING GOAL Compute and interpret various measures of risk as they apply.
As we wait for class to start, please sign in for today’s attendance tracking: Text to 37607: NewYork25 netID Go online to AEM 4160 class website Click.
RISK AND UNCERTAINTY Scarce resources create opportunities costs, which renders the idea of a zero-risk society a noble but unattainable goal. 1.
Cost effectiveness Analysis: Valuing Health; Valuing Research!
Lecture 12 Pricing Pharmaceuticals
Economic Evaluation of Health Interventions Basic Concepts
Value of Life and Traffic Injury Costs
Presentation transcript:

1 Civil Systems Planning Benefit/Cost Analysis Scott Matthews Courses: and Lecture /5/2003

and Economic valuations of life  Miller (n=29) $3 M in 1999 USD, surveyed  Wage risk premium method  WTP for safety measures  Behavioral decisions (e.g. seat belt use)  Foregone future earnings  Contingent valuation

and Specifics on Saving Lives  Cost-Utility Analysis  Quantity and quality of lives important  Just like discounting, lives are not equal  Back to the developing/developed example  But also: YEARS are not equal  Young lives “more important” than old  Cutting short a year of life for us vs  Cutting short a year of life for 85-year-old  Often look at ‘life years’ rather than ‘lives’ saved.. These values also get discounted

and Contingent Valuation  Analysis method used when there is no observable market  Example: water quality at national parks  Asks questions to population  Is a last resort option!  Called ‘contingent’ since you never really pay  Valuing use non-controversial  Valuing ‘non-use’ VERY controversial

and Example  Asked for valuations of a certain good  Then estimate overall WTP for it - similar to travel time demand functions  Extrapolated to entire population  Assumes random sample!

and Criticisms of CV  Extrapolation of ‘all CV studies’ to average consumer would take over their budget  Normal statistical problems (sampling, non-response, biases, etc.)  Surveying opinions is imprecise  Problems tend to be complicated

and WTP versus WTA  Economics implies that WTP should be equal to ‘willingness to accept’ loss  Turns out people want MUCH MORE in compensation for losing something  WTA is factor of 4-15 higher than WTP!  Also see discrepancy shrink with experience  WTP formats should be used in CVs  Only can compare amongst individuals

and Measuring Lives Saved  Life years (prevented fatalities) not equal  Qualitative and quantitative issue  Need to consider tradeoffs  Simple example from text  Status quo: no newborns survive a condition  Alt. A: 5 live, but with permanent disability  Alt. B: 2 live, but with low levels of disability  Which option (SQ, A, B) is preferable?  Assume Y increasing, H increasing  Equal costs, no relevant uncertainty

and Simple Example

and The Quality/Quantity Game  Assume “preference” for  Increased number of years lived  Increased level of health  Would your preferences be the same?  If so, SQ “dominated” by A and B  Note different horizontal/vertical preference  But which of A or B is better?  We all understand difference in years  Need an index of health status

and Health Status Index Death 0 Severely Disabled Minimally Disabled HealthModerately Disabled  Measures utility, derived from experts  Combine with Y values for QALYs  But this says nothing about tradeoff!  Can perform tradeoff survey  Value of “shorter Y, higher H” vs. opposite

and Methods  Health Rating method (see above)  Time tradeoff method  Standard gamble method  Discounting life years  Can/should we discount them?  Unlike cash values, we can’t make a decision to trade 1 year today for 10 yrs from now

and Example - MAIS scale  Abbreviated Injury Scale (AIS) is an anatomically based system that classifies individual injuries by body region on a six point ordinal scale of risk to life.  AIS does not assess the combined effects of multiple injuries.  The maximum AIS (MAIS) is the highest single AIS code for an occupant with multiple injuries.

and MAIS Table - Used for QALY Conversions Comprehensive Fatality / Injury Values Injury Severity1994 Relative Value MAIS MAIS MAIS MAIS MAIS Fatality1.0

and Risk Analysis  Study of the interactions between decision making, judgment, and nature  Evidence : cost-effectiveness of risk reduction opportunities varied widely - orders of magnitude  Economic efficiency problems

and Cost-Effectiveness of Life-Saving Interventions  From “500 Life-saving Interventions and Their Cost-Effectiveness”, Risk Analysis, Vol. 15, No. 3,  ‘References’ (eg #1127) are all other studies  Model:  Estimate costs of intervention vs. a baseline  Discount all costs  Estimate lives and life-years saved  Discount life years saved  CE = C I -C B /E I -E B

and Specific (Sample) Example  From p Ref no  Intervention: Rear outboard lap/shoulder belts in all (100%) of cars  Baseline: 95.8% of cars already in compliance  Intervention: require all cars made after 9/1/90 to have belts  Thus costs only apply to remaining 4% of cars  Target population: occupants over age 4  Others would be in child safety seats  What would costs be?

and Example (cont)  1986 Costs (from study): $6 cost per seat  Plus added fuel costs (due to increased weight) = total $791,000 over life of all cars produced  Effectiveness: expect 23 lives saved during 8.4 year lifetime of cars  But 95.8% already exist, thus only lives  Or lives per year (of use of car)  But these lives saved do not occur all in year 0 - they are spread out over 8.4 years.  Thus discount the effectiveness of lives saved per year into ‘year 0’ lives..

and Cost per life saved  With a 5% discount rate, the ‘present value’ of lives for 9 years = (less than 0.966)  Discounted lives saved =  0.115)/(1.05) j ; j=1..9  This is basically an annuity factor  So cost/life saved = $791,000/0.817  Or $967,700 per life (in “$1986/1986 lives”)  Using CPI: 145.8/ > $1,287,326 in $1993  But this tells us only the cost per life saved  We realistically care more about quality of life, which suggests using a quality index, e.g. life- years saved.

and Sample Life Expectancy Table 35-year old American expected to live 43.6 more years (newer data than our study) Source: National Center for Health Statistics,

and Cost per life-year saved  Assume average age of fatality in car accident was 35 years  Life expectancy tables suggest a 35 year old person would on average live to age 77  Thus ‘42’ life years saved per fatality avoided  1 life year for years  $1993 cost/life-year = $1,287,326/17.42  2 sig. figures: ~$74,000 as in paper  Note $1,287,326 is already in cost/life units -> just need to further scale for life-years by 17.42

and Example 2 - Incremental CE  Intervention: center (middle) lap/shoulder belts  Baseline: outboard only - (done above)  Same target population, etc.  Cost: $96,771,000  Incremental cost : $96,771,000 - $791,000  Effectiveness: 3 lives/yr, discounted  Incremental Effectiveness: =  Cost/life saved = $95.98 million/20.51 = $4.7 million ($1986) => $6.22 million in $1993  Cost/life-year=$6.22 million/17.42 = $360,000

and Overall Results in Paper  Some had $10B  Median $42k per life year saved  Some policies implemented, some only studied  Variation of 11 orders of magnitude!  Some maximums - $20 billion for benzene emissions control at tire factories  $100 billion for chloroform standards at paper mills

and Comparisons

and Agency Comparisons  $1993 Costs per life year saved for agencies:  FAA (Aviation): $23,000  CPSC (Consumer Products): $68,000  NHTSA (Highways):$78,000  OSHA (Worker Safety): $88,000  EPA (Environment): $7,600,000!  Are there underlying causes for range? Hint: are we comparing apples and oranges?